These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 10074926

  • 1. Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist.
    Egozi Y, Weisz B, Gana-Weisz M, Ben-Baruch G, Kloog Y.
    Int J Cancer; 1999 Mar 15; 80(6):911-8. PubMed ID: 10074926
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid.
    Marom M, Haklai R, Ben-Baruch G, Marciano D, Egozi Y, Kloog Y.
    J Biol Chem; 1995 Sep 22; 270(38):22263-70. PubMed ID: 7673206
    [Abstract] [Full Text] [Related]

  • 3. Dislodgment and accelerated degradation of Ras.
    Haklai R, Weisz MG, Elad G, Paz A, Marciano D, Egozi Y, Ben-Baruch G, Kloog Y.
    Biochemistry; 1998 Feb 03; 37(5):1306-14. PubMed ID: 9477957
    [Abstract] [Full Text] [Related]

  • 4. A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice.
    Weisz B, Giehl K, Gana-Weisz M, Egozi Y, Ben-Baruch G, Marciano D, Gierschik P, Kloog Y.
    Oncogene; 1999 Apr 22; 18(16):2579-88. PubMed ID: 10353601
    [Abstract] [Full Text] [Related]

  • 5. The Ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation.
    Gana-Weisz M, Haklai R, Marciano D, Egozi Y, Ben-Baruch G, Kloog Y.
    Biochem Biophys Res Commun; 1997 Oct 29; 239(3):900-4. PubMed ID: 9367867
    [Abstract] [Full Text] [Related]

  • 6. Targeting of K-Ras 4B by S-trans,trans-farnesyl thiosalicylic acid.
    Elad G, Paz A, Haklai R, Marciano D, Cox A, Kloog Y.
    Biochim Biophys Acta; 1999 Dec 09; 1452(3):228-42. PubMed ID: 10590312
    [Abstract] [Full Text] [Related]

  • 7. The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance.
    Gana-Weisz M, Halaschek-Wiener J, Jansen B, Elad G, Haklai R, Kloog Y.
    Clin Cancer Res; 2002 Feb 09; 8(2):555-65. PubMed ID: 11839677
    [Abstract] [Full Text] [Related]

  • 8. Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice.
    Sebti SM, Tkalcevic GT, Jani JP.
    Cancer Commun; 1991 May 09; 3(5):141-7. PubMed ID: 2043425
    [Abstract] [Full Text] [Related]

  • 9. Novel Ras antagonist blocks human melanoma growth.
    Jansen B, Schlagbauer-Wadl H, Kahr H, Heere-Ress E, Mayer BX, Eichler H, Pehamberger H, Gana-Weisz M, Ben-David E, Kloog Y, Wolff K.
    Proc Natl Acad Sci U S A; 1999 Nov 23; 96(24):14019-24. PubMed ID: 10570191
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The inhibition of human mesangial cell proliferation by S-trans, trans-farnesylthiosalicylic acid.
    Khwaja A, Sharpe CC, Noor M, Kloog Y, Hendry BM.
    Kidney Int; 2005 Aug 23; 68(2):474-86. PubMed ID: 16014024
    [Abstract] [Full Text] [Related]

  • 12. Stringent structural requirements for anti-Ras activity of S-prenyl analogues.
    Aharonson Z, Gana-Weisz M, Varsano T, Haklai R, Marciano D, Kloog Y.
    Biochim Biophys Acta; 1998 Feb 27; 1406(1):40-50. PubMed ID: 9545527
    [Abstract] [Full Text] [Related]

  • 13. The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.
    Reif S, Weis B, Aeed H, Gana-Weis M, Zaidel L, Avni Y, Romanelli RG, Pinzani M, Kloog Y, Bruck R.
    J Hepatol; 1999 Dec 27; 31(6):1053-61. PubMed ID: 10604579
    [Abstract] [Full Text] [Related]

  • 14. Arglabin-DMA, a plant derived sesquiterpene, inhibits farnesyltransferase.
    Shaikenov TE, Adekenov SM, Williams RM, Prashad N, Baker FL, Madden TL, Newman R.
    Oncol Rep; 2001 Dec 27; 8(1):173-9. PubMed ID: 11115593
    [Abstract] [Full Text] [Related]

  • 15. Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects.
    Smalley KS, Eisen TG.
    Int J Cancer; 2002 Apr 01; 98(4):514-22. PubMed ID: 11920610
    [Abstract] [Full Text] [Related]

  • 16. A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells.
    Halaschek-Wiener J, Wacheck V, Schlagbauer-Wadl H, Wolff K, Kloog Y, Jansen B.
    Mol Med; 2000 Aug 01; 6(8):693-704. PubMed ID: 11055588
    [Abstract] [Full Text] [Related]

  • 17. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
    Liu M, Bryant MS, Chen J, Lee S, Yaremko B, Li Z, Dell J, Lipari P, Malkowski M, Prioli N, Rossman RR, Korfmacher WA, Nomeir AA, Lin CC, Mallams AK, Doll RJ, Catino JJ, Girijavallabhan VM, Kirschmeier P, Bishop WR.
    Cancer Chemother Pharmacol; 1999 Aug 01; 43(1):50-8. PubMed ID: 9923541
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.